Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $18.8 million.

  • Mesa Laboratories' Cash from Operations rose 344.75% to $18.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $41.5 million, marking a year-over-year decrease of 1167.86%. This contributed to the annual value of $46.8 million for FY2025, which is 606.12% up from last year.
  • As of Q4 2025, Mesa Laboratories' Cash from Operations stood at $18.8 million, which was up 344.75% from $8.2 million recorded in Q3 2025.
  • Mesa Laboratories' Cash from Operations' 5-year high stood at $18.8 million during Q4 2025, with a 5-year trough of -$2.8 million in Q2 2022.
  • Its 5-year average for Cash from Operations is $10.0 million, with a median of $10.2 million in 2022.
  • As far as peak fluctuations go, Mesa Laboratories' Cash from Operations plummeted by 12931.48% in 2022, and later skyrocketed by 45357.52% in 2023.
  • Over the past 5 years, Mesa Laboratories' Cash from Operations (Quarter) stood at $15.9 million in 2021, then plummeted by 51.45% to $7.7 million in 2022, then surged by 49.46% to $11.5 million in 2023, then surged by 57.17% to $18.1 million in 2024, then rose by 3.45% to $18.8 million in 2025.
  • Its last three reported values are $18.8 million in Q4 2025, $8.2 million for Q3 2025, and $1.9 million during Q2 2025.